Lunit Announces Completion of Volpara Acquisition to Advance AI ...
May 22, 2024 — Lunit, a provider of Artificial intelligence (AI)-powered solutions for cancer diagnostics and ...
Lunit Partners with Radiobotics to Enhance Diagnostic Synergies in AI ...
May 22, 2024 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, recently ...
Volpara Launches MQSA Compliance Software at the Society for Breast ...
April 11, 2024 — Volpara Health Technologies Ltd., a global leader in software for the early detection and prevention of ...
Lunit SCOPE IO Reveals Promising Results in Neoadjuvant Immunotherapy ...
April 8, 2024 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today ...
Volpara to Showcase AI Software for Breast Centers at NCBC 2024 ...
March 18, 2024 — Volpara Health Technologies Ltd., a global leader in software for the early detection and prevention of ...
Lunit AI Solutions to Power Samsung's X-ray Devices for Advanced Chest ...
January 16, 2024 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced ...
Lunit to Acquire Volpara: Scheme Implementation Agreement Signed
December 14, 2023 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today ...
Lunit Nets FDA Nod for AI-Powered 3D Breast Tomosynthesis Solution ...
November 22, 2023 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today ...
First Immunotherapy Success in TKI-Resistant Lung Cancer Setting ...
October 24, 2023 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today ...
Lunit and Leeds Teaching Hospitals NHS Trust to Launch World's First ...
October 6, 2023 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, and Leeds ...